Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selene Cipri

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Critical Reviews in Oncology/Hematology|June 4, 2026
Brain tumor susceptibility: from genetic predisposition syndromes to extended characterization of genomic determinantsMarta Aprile, Vanessa Callegari, Selene Cipri, et al.
Frontiers in Oncology|June 3, 2026
Case Report: The revelation of a new pathogenic variant in the POT1 gene in a patient with a pediatric high-grade glioma and a renal cell carcinomaSelene Cipri, Antonella Cacchione, Annalisa Serra, et al.
Frontiers in Immunology|June 21, 2023
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-GStefano Mocci, Roberto Littera, Luchino Chessa, et al.
Frontiers in Immunology|August 13, 2025
The role of HLA-G in primary biliary cholangitis and response to therapyMichela Miglianti, Stefano Mocci, Roberto Littera, et al.
HGG Advances|June 27, 2026
Pediatric High-Grade Gliomas and Cancer Predisposition Syndromes: A Retrospective StudySelene Cipri, Giada Del Baldo, Emanuele Agolini, et al.
Frontiers in Immunology|October 31, 2022
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitisRoberto Littera, Andrea Perra, Michela Miglianti, et al.
Frontiers in Immunology|December 21, 2020
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian ExperienceRoberto Littera, Marcello Campagna, Silvia Deidda, et al.
Plos One|August 5, 2021
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infectionRoberto Littera, Luchino Chessa, Silvia Deidda, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Critical Reviews in Oncology/Hematology|June 4, 2026
Brain tumor susceptibility: from genetic predisposition syndromes to extended characterization of genomic determinantsMarta Aprile, Vanessa Callegari, Selene Cipri, et al.
Frontiers in Oncology|June 3, 2026
Case Report: The revelation of a new pathogenic variant in the POT1 gene in a patient with a pediatric high-grade glioma and a renal cell carcinomaSelene Cipri, Antonella Cacchione, Annalisa Serra, et al.
Frontiers in Immunology|June 21, 2023
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-GStefano Mocci, Roberto Littera, Luchino Chessa, et al.
Frontiers in Immunology|August 13, 2025
The role of HLA-G in primary biliary cholangitis and response to therapyMichela Miglianti, Stefano Mocci, Roberto Littera, et al.
HGG Advances|June 27, 2026
Pediatric High-Grade Gliomas and Cancer Predisposition Syndromes: A Retrospective StudySelene Cipri, Giada Del Baldo, Emanuele Agolini, et al.
Frontiers in Immunology|October 31, 2022
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitisRoberto Littera, Andrea Perra, Michela Miglianti, et al.
Frontiers in Immunology|December 21, 2020
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian ExperienceRoberto Littera, Marcello Campagna, Silvia Deidda, et al.
Plos One|August 5, 2021
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infectionRoberto Littera, Luchino Chessa, Silvia Deidda, et al.
Pageof 2